Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Assets: 2012-2025

Historic Return on Assets for Ani Pharmaceuticals (ANIP) over the last 14 years, with Sep 2025 value amounting to 0.03%.

  • Ani Pharmaceuticals' Return on Assets rose 4.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 4.00%. This contributed to the annual value of -0.02% for FY2024, which is 4.00% down from last year.
  • Per Ani Pharmaceuticals' latest filing, its Return on Assets stood at 0.03% for Q3 2025, which was up 479.30% from -0.01% recorded in Q2 2025.
  • Ani Pharmaceuticals' 5-year Return on Assets high stood at 0.04% for Q1 2024, and its period low was -0.09% during Q3 2022.
  • Over the past 3 years, Ani Pharmaceuticals' median Return on Assets value was -0.01% (recorded in 2023), while the average stood at 0.00%.
  • In the last 5 years, Ani Pharmaceuticals' Return on Assets increased by 11bps in 2023 and then fell by 6bps in 2025.
  • Quarterly analysis of 5 years shows Ani Pharmaceuticals' Return on Assets stood at -0.07% in 2021, then remained steady at -0.06% in 2022, then increased by 8bps to 0.02% in 2023, then dropped by 4bps to -0.01% in 2024, then rose by 4bps to 0.03% in 2025.
  • Its Return on Assets stands at 0.03% for Q3 2025, versus -0.01% for Q2 2025 and -0.02% for Q1 2025.